New immunotherapy drugs target two evasive cancer-driving proteins. The journal Science highlighted the three publications describing the generation of new antibodies targeting cancer-specific alterations in solid and hematologic malignancies.

https://www.science.org/content/article/new-immunotherapy-drugs-target-two-evasive-cancer-driving-proteins